Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Voluminous Blood Transfusion Ineffectual in Hip Surgery

By HospiMedica International staff writers
Posted on 28 Dec 2011
Hip-fracture patients with an increased cardiovascular (CV) risk gained no survival or functional benefits from liberal use of blood transfusions, according to a new study.

Researchers at the University of Medicine and Dentistry of New Jersey (UMDNJ; New Brunswick, USA) conducted a randomized trial involving 2,016 patients (50 years of age or older), who had either a history of or risk factors for CV disease, and whose hemoglobin level was below 10 g per deciliter after hip-fracture surgery. More...
The researchers randomly assigned patients to a liberal transfusion strategy, receiving a median of two units of red blood cells (RBCs), or a restrictive strategy, receiving 65% fewer units of blood, with half of the restrictive patients receiving no transfusions at all. The primary outcome was death or an inability to walk across a room without human assistance on 60-day follow-up.

The results showed that 35% of patients in the liberal-transfusion group met the primary endpoint, compared with 34.7% of patients randomized to the restrictive transfusion strategy. Additionally, 4.3% of the liberal-transfusion arm had an acute coronary syndrome or died in hospital, compared with 5.2% of patients in the restrictive-transfusion arm. The 60-day mortality was 7.6% with the liberal transfusion strategy and 6.6% with the restrictive strategy; complication rates also were similar between the two groups. The study was published ahead of print on December 14, 2011, in the New England Journal of Medicine (NEJM).

“It is reasonable to withhold transfusion in patients who have undergone surgery in the absence of symptoms of anemia or a decline in the hemoglobin level below 8 g per deciliter, even in elderly patients with underlying cardiovascular disease or risk factors,” concluded lead author Jeffrey Carson, MD, and colleagues. “A liberal transfusion strategy, as compared with a restrictive strategy, did not reduce rates of death or inability to walk independently on 60-day follow-up or reduce in-hospital morbidity in elderly patients at high cardiovascular risk.”

Related Links:

University of Medicine and Dentistry of New Jersey



Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Surgical System
Stealth AXiS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.